CERS
Closed
Cerus Corporation
1.48
+0.07 (+4.96%)
Last Update: 01 Jul 2025 23:01:00
Yesterday: 1.41
Day's Range: 1.37 - 1.5
Send
sign up or login to leave a comment!
When Written:
2.97
Cerus Corporation is a biomedical company that develops and commercializes systems and pathogen-inactivated blood products. The company's INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens that may be present in donated blood. The system is currently approved for use in the United States, Europe, and other countries. Cerus also develops pathogen-inactivated platelet and plasma products for transfusion, as well as innovative therapies for the treatment of cancer and infectious diseases. The company was founded in 1991 and is headquartered in Concord, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








